Zdrowie i gospodarka · 16/10/2015
FDA Announces Draft Recommendations for Triethylamine and Methylisobutylketone Residual Solvents
The FDA is releasing draft guidelines for the acceptable daily exposure limits of triethylamine and methylisobutylketone in pharmaceuticals, in line with the International Conference on Harmonisation's (ICH) technical requirements for pharmaceutical registration.